- Home
- DQ vs BCYC Comparison
DQ vs BCYC Comparison
Compare DQ & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DQ
- BCYC
- Stock Information
- Founded
- DQ 2006
- BCYC 2009
- Country
- DQ China
- BCYC United Kingdom
- Employees
- DQ N/A
- BCYC N/A
- Industry
- DQ Semiconductors
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- DQ Technology
- BCYC Health Care
- Exchange
- DQ Nasdaq
- BCYC Nasdaq
- Market Cap
- DQ 1.4B
- BCYC 1.7B
- IPO Year
- DQ 2010
- BCYC 2019
- Fundamental
- Price
- DQ $18.30
- BCYC $15.69
- Analyst Decision
- DQ Hold
- BCYC Buy
- Analyst Count
- DQ 5
- BCYC 9
- Target Price
- DQ $20.31
- BCYC $36.00
- AVG Volume (30 Days)
- DQ 896.9K
- BCYC 880.7K
- Earning Date
- DQ 10-30-2024
- BCYC 10-31-2024
- Dividend Yield
- DQ N/A
- BCYC N/A
- EPS Growth
- DQ N/A
- BCYC N/A
- EPS
- DQ N/A
- BCYC N/A
- Revenue
- DQ $1,310,019,000.00
- BCYC $36,898,000.00
- Revenue This Year
- DQ N/A
- BCYC $40.52
- Revenue Next Year
- DQ $47.64
- BCYC N/A
- P/E Ratio
- DQ N/A
- BCYC N/A
- Revenue Growth
- DQ N/A
- BCYC 48.60
- 52 Week Low
- DQ $13.62
- BCYC $12.17
- 52 Week High
- DQ $30.85
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- DQ 44.43
- BCYC 37.83
- Support Level
- DQ $16.92
- BCYC $12.17
- Resistance Level
- DQ $18.75
- BCYC $21.50
- Average True Range (ATR)
- DQ 1.06
- BCYC 1.36
- MACD
- DQ -0.13
- BCYC -0.36
- Stochastic Oscillator
- DQ 26.67
- BCYC 49.67
About DQ DAQO New Energy Corp.
Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.